Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Interest Coverage Ratio (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Interest Coverage Ratio for 10 consecutive years, with 4.78 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 168.05% year-over-year to 4.78, compared with a TTM value of 7.89 through Dec 2025, up 33.33%, and an annual FY2025 reading of 7.89, up 33.33% over the prior year.
  • Interest Coverage Ratio was 4.78 for Q4 2025 at Zevra Therapeutics, up from 2.02 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 364.56 in Q2 2021 and bottomed at 604.07 in Q2 2022.
  • Average Interest Coverage Ratio over 5 years is 79.16, with a median of 27.87 recorded in 2024.
  • Peak annual rise in Interest Coverage Ratio hit 16729.21% in 2021, while the deepest fall reached 35406.82% in 2021.
  • Year by year, Interest Coverage Ratio stood at 568.4 in 2021, then skyrocketed by 90.42% to 54.43 in 2022, then soared by 64.35% to 19.41 in 2023, then skyrocketed by 63.79% to 7.03 in 2024, then soared by 168.05% to 4.78 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ZVRA at 4.78 in Q4 2025, 2.02 in Q3 2025, and 35.36 in Q2 2025.